| Literature DB >> 32571399 |
Carlijn M Maasakkers1, René J F Melis1, Roy P C Kessels2,3, Paul A Gardiner4, Marcel G M Olde Rikkert5, Dick H J Thijssen6,7, Jurgen A H R Claassen8.
Abstract
BACKGROUND: Sedentary behaviour might be a potential risk factor for cognitive decline. However, the short-term effects of sedentary behaviour on (cerebro) vascular and cognitive performance in older people are unknown.Entities:
Keywords: Cerebral vasculature; Cognitive decline; Dementia; Physical inactivity; Sitting
Mesh:
Year: 2020 PMID: 32571399 PMCID: PMC7310280 DOI: 10.1186/s13195-020-00644-z
Source DB: PubMed Journal: Alzheimers Res Ther Impact factor: 6.982
Fig. 1Study Design. Study design, with four conditions shown horizontally. During SIT- people stayed seated for three hours while watching television. In the BREAK- condition people interrupted their television watching with two-minute walking breaks. The SIT+ and BREAK+ condition are similar to the SIT- and BREAK- conditions, except for mental activity, which was kept high with cognitive puzzles. Before and after each condition measurements were conducted
Participant characteristics
| Variable | Mean (SD) / Percentage (n) |
|---|---|
| Age (years, (SD)) | 78 (5.3) |
| Sex (% women, (n)) | 41% (9) |
| BMI (kg/m2, (SD)) | 26 (4.0) |
| SBP/DBP¥ (mmHg, (SD)) | 151 / 83 (22 / 13) |
| MoCA (score, (SD)) | 26* (2) |
| Self-reported comorbidities (%, (n)) | |
| Myocardial infarction | 18% (4) |
| Arterial fibrillation | 5% (1) |
| Hypertension | 41% (9) |
| Hypercholesterolemia | 18% (4) |
| Diabetes | 0% (0) |
| Arthrosis | 27% (6) |
| Medication use (%, (n)) | |
| Antihypertensive drugs | 50% (11) |
| ARB | 18% (4) |
| ACE inhibitor | 23% (5) |
| Diuretic | 18% (4) |
| Beta blocker | 23% (5) |
| Calcium channel blocker | 5% (1) |
| Statins | 23% (5) |
| Antithrombotic agents | 23% (5) |
| Activity pattern by activPAL† | |
| Sedentary time (hours/day, (SD)) | 10.3 (1.6) |
| Sleep time (hours/day, (SD)) | 8.2 (0.9) |
Abbreviations: BMI Body Mass Index, SBP systolic blood pressure, DBP diastolic blood pressure, MoCA Montreal Cognitive Assesment, ARB angiotensin II receptor blocker, ACE angiotensin-converting-enzyme. ¥Blood pressure measured with an automatic oscillometric device. *Score out of a maximum of 30. †N = 21 due to one activPAL measurement with too few measurement days
Fig. 2Cognitive outcome measures. Alertness reaction times, flexibility scores (higher = better), and error percentages for working memory 1 and 2 before and after the three-hour period per condition. N = 22. Purple continuous line SIT-, purple dotted line BREAK-, blue continuous line SIT+, and blue dotted line BREAK+. Mean values are shown with SDs
Fig. 3Hemodynamic outcome measures. Systolic, diastolic and mean arterial pressure measured by Finapres NOVA, heart rate, cerebral blood flow, and cerebral resistance before and after the three-hour period per condition. Purple continuous line SIT-, purple dotted line BREAK-, blue continuous line SIT+, and blue dotted line BREAK+. Mean values are shown with SDs. P-values represent the time effect over three hours. For SBP, DBP, Mean arterial BP, and HR N = 20 (except for SIT+ N = 19). For CBF and CVR N = 16 for SIT-, N = 15 for BREAK- and BREAK+, N = 17 for SIT+
Cerebral autoregulation parameters per condition and time point
| SIT- | BREAK- | SIT+ | BREAK+ | |||||
|---|---|---|---|---|---|---|---|---|
| Before | After | Before | After | Before | After | Before | After | |
| 11 | 10 | 12 | 9 | 12 | 12 | 10 | 11 | |
| 0.60 (0.34) | 0.43 (0.10) | 0.54 (0.13) | 0.49 (0.13) | 0.47 (0.12) | 0.47 (0.21) | 0.50 (0.19) | 0.46 (0.14) | |
| 1.3 (0.61) | 1.1 (0.26) | 1.3 (0.29) | 1.1 (0.35) | 1.2 (0.36) | 1.1 (0.34) | 1.2 (0.29) | 1.2 (0.41) | |
| 42.8 (14.6) | 54.4 (16.2) | 50.8 (19.2) | 61.0 (16.4) | 43.7 (17.6) | 54.7 (18.7) | 45.0 (14.6) | 51.5 (14.2) | |
| 11 | 13 | 15 | 14 | 14 | 13 | 11 | 12 | |
| 0.63 (0.29) | 0.53 (0.16) | 0.70 (0.19) | 0.68 (0.19) | 0.67 (0.26) | 0.60 (0.23) | 0.63 (0.28) | 0.60 (0.19) | |
| 1.6 (0.59) | 1.4 (0.34) | 1.6 (0.34) | 1.6 (0.38) | 1.6 (0.37) | 1.6 (0.43) | 1.5 (0.40) | 1.4 (0.43) | |
| 25.6 (8.0) | 32.7 (11.0) | 29.7 (9.2) | 25.8 (11.1) | 31.6 (12.5) | 28.4 (13.1) | 33.0 (12.1) | 27.9 (14.4) | |
Values represent the mean (SD). Abbreviations: VLF very-low-frequency, LF low-frequency, norm normalised, N number of participants. *Phase of the VLF increased significantly after three hours (11.0 (3.52;18.46), P = 0.01) in all conditions